In a move poised to enhance its expertise in the life sciences sector, McGuireWoods has added Kevin Madagan and Clint Narver as partners specializing in health care and life sciences in its Washington office, the firm announced Wednesday.
Kevin Madagan brings a depth of experience in the development and commercialization of drugs, biologics, devices, and dietary supplements. His clientele spans a diverse array of stakeholders including clinical trial sponsors, manufacturers, clinical laboratories, and third-party logistics providers. Madagan was previously affiliated with Reed Smith, where he sharpened his focus on FDA regulatory and compliance matters, particularly in relation to enforcement actions.
Clint Narver, formerly with the U.S. Food and Drug Administration, will concentrate on guiding clients through intricate FDA regulatory and compliance landscapes. His expertise extends to advising on FDA-related investigations and enforcement strategies.
These appointments mark a strategic effort by McGuireWoods to bolster its capabilities in the life sciences field, particularly in the realm of FDA compliance and regulatory issues. For further details, you can refer to a release on the firm’s official website.